Characteristics of Patients With Ulcerative Colitis Initiating Vedolizumab Therapy in Real-World Clinical Practice

被引：0
|
作者：
Khalid, Javaria M. [1 ]
Reynolds, Matthew [2 ]
Alam, Naufi L. [3 ]
Don, O'Hara [2 ]
Smyth, Michael D. L. [1 ]
机构：
[1] Takeda Dev Ctr Europe Ltd, London, England
[2] Evidera, Lexington, MA USA
[3] Evidera, London, England
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01946
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1946
引用
收藏
页码：S825 / S825
页数：1
相关论文
共 50 条
  • [1] Characteristics of Patients With Crohn's Disease Initiating Vedolizumab Therapy in Real-World Clinical Practice
    Khalid, Javaria M.
    Reynolds, Matthew
    Alam, Naufil
    Don, O'Hara
    Smyth, Michael D. L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S773 - S774
  • [2] Clinical characteristics of patients with Crohn's disease or ulcerative colitis treated with vedolizumab: a real-world data analysis
    Liang, H.
    Manne, S.
    Shick, J.
    Yu, S.
    Fusco, G.
    Dolin, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S466 - S467
  • [3] Clinical Characteristics of Patients With Crohn's Disease or Ulcerative Colitis Treated With Vedolizumab - A Real-World Data Analysis
    Liang, Huifang
    Manne, Sudhakar
    Shick, Jesse
    Yu, Shawn
    Fusco, Gregory
    Dolin, Paul
    GASTROENTEROLOGY, 2016, 150 (04) : S789 - S789
  • [4] Hospitalisations and characteristics of patients with ulcerative colitis and Crohn's disease treated with vedolizumab in real-world clinical practice: results from a multicentre study
    Reynolds, M.
    Alam, N.
    Raluy, M.
    Gardstein, B.
    O'Hara, D.
    Smyth, M.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S214 - S214
  • [5] A real-world study of outcomes in biologic-naive patients with Crohn's disease and ulcerative colitis initiating vedolizumab
    Raluy, M.
    Alam, N.
    Donaldson, R.
    Smyth, M.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S238 - S238
  • [6] Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)
    Pulusu, S. S. R.
    Srinivasan, A.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Keung, C.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q. -U. -A.
    Su, H.
    Leung, W. -K.
    Edmundson, A.
    Cooke, S.
    Mahy, G.
    Thin, L.
    Radford-Smith, G.
    Sparrow, M.
    Andrews, J. M.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Ng, S.
    Travis, S.
    Lawrance, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S395 - S396
  • [7] The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
    Ye, Byong Duk
    Cheon, Jae Hee
    Song, Ki Hwan
    Kim, Joo Sung
    Kim, Young-Ho
    Yoon, Hyuk
    Lee, Kang-Moon
    Kang, Sang-Bum
    Jang, Byung Ik
    Park, Jae Jun
    Kim, Tae Oh
    Lee, Dae-Wook
    Foo, Chee Yoong
    Shin, Jeong Eun
    Park, Dong Il
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [8] Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
    Nomura, Kei
    Shibuya, Tomoyoshi
    Odakura, Rina
    Haraikawa, Mayuko
    Ishino, Hirotaka
    Orikasa, Masayuki
    Omori, Masashi
    Koma, Masao
    Ito, Kentaro
    Maruyama, Takafumi
    Nomura, Osamu
    Ishikawa, Dai
    Hojo, Mariko
    Nagahara, Akihito
    BIOMEDICINES, 2024, 12 (09)
  • [9] A SINGLE-CENTRE, REAL-WORLD EXPERIENCE OF TREATING ULCERATIVE COLITIS PATIENTS WITH VEDOLIZUMAB
    Lenti, M. V.
    Cococcia, S.
    Giuffrida, P.
    Aronico, N.
    Soriano, S.
    Corazza, G. R.
    Di Sabatino, A.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E202 - E203
  • [10] Real-world treatment persistence with vedolizumab in Crohn's disease and ulcerative colitis patients
    Raluy, M.
    Fraeman, K.
    Donaldson, R.
    Reynolds, M.
    Smyth, M.
    Demuth, D.
    Khalid, J. M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S173 - S174
12345